These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7468579)
21. Breast cancer among young U.S. women in relation to oral contraceptive use. White E; Malone KE; Weiss NS; Daling JR J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534 [TBL] [Abstract][Full Text] [Related]
26. Characteristics that predict risk of breast cancer before and after the menopause. Paffenbarger RS; Kampert JB; Chang HG Am J Epidemiol; 1980 Aug; 112(2):258-68. PubMed ID: 7416152 [TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and breast cancer. IPPF Med Bull; 1989 Aug; 23(4):3. PubMed ID: 12315867 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for benign breast disease: a case-control study of discordant twins. Odenheimer DJ; Zunzunegui MV; King MC; Shipler CP; Friedman GD Am J Epidemiol; 1984 Oct; 120(4):565-71. PubMed ID: 6540984 [TBL] [Abstract][Full Text] [Related]
29. Weighing the evidence on the pill and breast cancer. Johnson JH Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859 [TBL] [Abstract][Full Text] [Related]
30. Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women. Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; Goldenberg IS; White C Am J Epidemiol; 1984 Jul; 120(1):87-96. PubMed ID: 6741927 [TBL] [Abstract][Full Text] [Related]
31. Benign breast disease and oral contraceptive use. Janerich DT; Glebatis DM; Dugan JM JAMA; 1977 May; 237(20):2199-201. PubMed ID: 576904 [TBL] [Abstract][Full Text] [Related]
32. Incidence rates and risk factors of benign breast neoplasms. Cole P; Mark Elwood J; Kaplan SD Am J Epidemiol; 1978 Aug; 108(2):112-20. PubMed ID: 707472 [TBL] [Abstract][Full Text] [Related]
33. The evaluation of the data collection process for a multicenter, population-based, case-control design. Wingo PA; Ory HW; Layde PM; Lee NC Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827 [TBL] [Abstract][Full Text] [Related]
34. Oral contraception and breast pathology. Ragni N; Boccardo E; Viglino S; Larosa E Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288 [TBL] [Abstract][Full Text] [Related]
35. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme. Lancet; 1973 Jun; 1(7817):1399-404. PubMed ID: 4126154 [TBL] [Abstract][Full Text] [Related]
36. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy. Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A Popul Sci; 1982; (3):157-68. PubMed ID: 12266214 [TBL] [Abstract][Full Text] [Related]
37. Oral contraceptive use and the risk of breast cancer in women with a "prior" history of benign breast disease. Stadel BV; Schlesselman JJ Am J Epidemiol; 1986 Mar; 123(3):373-82. PubMed ID: 3946384 [TBL] [Abstract][Full Text] [Related]
38. Exogenous progestins and breast cancer. Stanford JL; Thomas DB Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216 [TBL] [Abstract][Full Text] [Related]
39. Combined oral contraceptives: risks and benefits. Thorogood M; Villard-Mackintosh L Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603 [TBL] [Abstract][Full Text] [Related]
40. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice. Smith LF; Whitfield MJ Br J Gen Pract; 1995 Aug; 45(397):409-14. PubMed ID: 7576845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]